Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Scopolamine Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Scopolamine Market Status and Forecast (2016-2027)
      • 1.3.2 Global Scopolamine Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Scopolamine Supply by Company

    • 2.1 Global Scopolamine Sales Volume by Company
    • 2.2 Global Scopolamine Sales Value by Company
    • 2.3 Global Scopolamine Price by Company
    • 2.4 Scopolamine Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Scopolamine Market Status by Category

    • 3.1 Scopolamine Category Introduction
      • 3.1.1 Scopolamine Butylbromide
      • 3.1.2 Scopolamine Hydrobromide
      • 3.1.3 Scopolamine Base
    • 3.2 Global Scopolamine Market by Category
      • 3.2.1 Global Scopolamine Sales Volume by Category (2016-2021)
      • 3.2.2 Global Scopolamine Sales Value by Category (2016-2021)
      • 3.2.3 Global Scopolamine Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Scopolamine Market Status by End User/Segment

    • 4.1 Scopolamine Segment by End User/Segment
      • 4.1.1 Oral
      • 4.1.2 Injection
      • 4.1.3 Patches
    • 4.2 Global Scopolamine Market by End User/Segment
      • 4.2.1 Global Scopolamine Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Scopolamine Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Scopolamine Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Scopolamine Market Status by Region

    • 5.1 Global Scopolamine Market by Region
      • 5.1.1 Global Scopolamine Sales Volume by Region
      • 5.1.2 Global Scopolamine Sales Value by Region
    • 5.2 North America Scopolamine Market Status
    • 5.3 Europe Scopolamine Market Status
    • 5.4 Asia Pacific Scopolamine Market Status
    • 5.5 Central & South America Scopolamine Market Status
    • 5.6 Middle East & Africa Scopolamine Market Status

    6 North America Scopolamine Market Status

    • 6.1 North America Scopolamine Market by Country
      • 6.1.1 North America Scopolamine Sales Volume by Country (2016-2021)
      • 6.1.2 North America Scopolamine Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Scopolamine Market Status

    • 7.1 Europe Scopolamine Market by Country
      • 7.1.1 Europe Scopolamine Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Scopolamine Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Scopolamine Market Status

    • 8.1 Asia Pacific Scopolamine Market by Country
      • 8.1.1 Asia Pacific Scopolamine Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Scopolamine Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Scopolamine Market Status

    • 9.1 Central & South America Scopolamine Market by Country
      • 9.1.1 Central & South America Scopolamine Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Scopolamine Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Scopolamine Market Status

    • 10.1 Middle East & Africa Scopolamine Market by Country
      • 10.1.1 Middle East & Africa Scopolamine Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Scopolamine Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Sales Channel, Distributors and Buyers

    • 11.1 Sales Channel
      • 11.1.1 Direct Sales
      • 11.1.2 Channel Sales
    • 11.2 Scopolamine Distributors
    • 11.3 Scopolamine Buyers

    12 Global Scopolamine Market Forecast by Category and by End User/Segment

    • 12.1 Global Scopolamine Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Scopolamine Forecast by Category
      • 12.2.1 Global Scopolamine Sales Volume Forecast by Category
      • 12.2.2 Global Scopolamine Sales Value Forecast by Category
      • 12.2.3 Global Scopolamine Price Forecast by Category
    • 12.3 Global Scopolamine Forecast by End User/Segment
      • 12.3.1 Global Scopolamine Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Scopolamine Sales Value Forecast by End User/Segment
      • 12.3.3 Global Scopolamine Price Forecast by End User/Segment

    13 Global Scopolamine Market Forecast by Region/Country

    • 13.1 Global Scopolamine Market Forecast by Region (2022-2027)
      • 13.1.1 Global Scopolamine Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Scopolamine Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Alkaloids of Australia
      • 14.1.1 Company Information
      • 14.1.2 Scopolamine Product Introduction
      • 14.1.3 Alkaloids of Australia Scopolamine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 Contact Information
    • 14.2 Boehringer Ingelheim
      • 14.2.1 Company Information
      • 14.2.2 Scopolamine Product Introduction
      • 14.2.3 Boehringer Ingelheim Scopolamine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 Contact Information
    • 14.3 Fine Chemicals Corporation
      • 14.3.1 Company Information
      • 14.3.2 Scopolamine Product Introduction
      • 14.3.3 Fine Chemicals Corporation Scopolamine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 Contact Information
    • 14.4 Phytex Australia
      • 14.4.1 Company Information
      • 14.4.2 Scopolamine Product Introduction
      • 14.4.3 Phytex Australia Scopolamine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 Contact Information
    • 14.5 Alchem International
      • 14.5.1 Company Information
      • 14.5.2 Scopolamine Product Introduction
      • 14.5.3 Alchem International Scopolamine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 Contact Information
    • 14.6 Guangzhou Hanfang
      • 14.6.1 Company Information
      • 14.6.2 Scopolamine Product Introduction
      • 14.6.3 Guangzhou Hanfang Scopolamine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 Contact Information
    • 14.7 Alkaloids Corporation
      • 14.7.1 Company Information
      • 14.7.2 Scopolamine Product Introduction
      • 14.7.3 Alkaloids Corporation Scopolamine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 Contact Information
    • 14.8 Luyin
      • 14.8.1 Company Information
      • 14.8.2 Scopolamine Product Introduction
      • 14.8.3 Luyin Scopolamine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 Contact Information

    15 Conclusion

    Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Scopolamine market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Scopolamine market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

    Segmented by Category
    Scopolamine Butylbromide
    Scopolamine Hydrobromide
    Scopolamine Base

    Segmented by End User/Segment
    Oral
    Injection
    Patches

    Segmented by Country
    North America
    United States
    Canada
    Mexico
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Asia Pacific
    China
    Japan
    Korea
    Southeast Asia
    India
    Australasia
    Central & South America
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Iran
    Israel
    Turkey
    South Africa
    Saudi Arabia

    Key manufacturers included in this survey
    Alkaloids of Australia
    Boehringer Ingelheim
    Fine Chemicals Corporation
    Phytex Australia
    Alchem International
    Guangzhou Hanfang
    Alkaloids Corporation
    Luyin
    Buy now